How can companies ensure that their investments in clinical trials pay off with success in the marketplace?
Clinical Trial Design for Commercial Success provides expert insights on building clinical trials that give new drugs every advantage in the marketplace, from launch to patent expiry. Learn who needs to be involved - and the part they play - in delivering clinical trials that bring successful drugs to market. Learn more.
The FDA said Friday that it broadened the indication for Bristol-Myers Squibb's Opdivo (nivolumab) to include patients with advanced non-squamous non-small-cell lung cancer (NSCLC) whose disease... Read More >>